Abiopharma

TRF-1 mantém decisões favoráveis ao Projeto Potássio Autazes e impede o encaminhamento de recursos aos tribunais superiores do Brasil

Beamr Issues Q2-2026 CEO Letter to Shareholders: Expanding Our Reach into Autonomous Vehicle Teams

Brazil’s Court of Appeal Perserves Rulings Favourable to the Autazes Potash Project, Blocks Referral of Appeals to Superior Courts

Ceragon Reports 2026 Second Quarter Financial Results

CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates

Terrestrial Energy Reports Second Quarter 2026 Results

IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

The Middleby Corporation Reports Second Quarter Results

AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD)